skip to main content
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Results 1 2 3 4 5 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Material Type:
Article
Add to e-Shelf

Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma final overall survival results of a randomised, open-label, phase 3 study

Tadeusz Robak Jie Jin; Halyna Pylypenko; Gregor Verhoef; Noppadol Siritanaratkul; Johannes Drach; Markus Raderer; Jiri Mayer; Juliana Pereira; Gayane Tumyan

Lancet oncology v. 19, n. 11, p. 1449-1458, 2018

New York 2018

Online access. The library also has physical copies.

2
Material Type:
Article
Add to e-Shelf

Association between quality of response and outcomes in patients with newly diagnosed mantle cell lymphoma receiving VR-CAP versus R-CHOP in the phase 3 LYM-3002 study

Gregor Verhoef Tadeusz Robak; Huiqiang Huang; Halyna Pylypenko; Noppadol Siritanaratkul; Juliana Pereira; Johannes Drach; Jiri Mayer; Rumiko Okamoto; Lixia Pei; Brendan Rooney; Andrew Cakana; Helgi van de Velde; Franco Cavalli

Haematologica Pavia v. 102, n. 5, p. 895-902, 2017

Pavia 2017

Online access. The library also has physical copies.

3
Material Type:
Article
Add to e-Shelf

Association between bortezomib dose intensity and overall survival in mantle cell lymphoma patients on frontline VR-CAP in the phase 3 LYM-3002 study(*)

Tadeusz Robak Huiqiang Huang; Jie Jin; Jun Zhu; Ting Liu; Olga Samoilova; Halyna Pylypenko; Gregor Verhoef; Noppadol Siritanaratkul; Evgenii Osmanov; Juliana Pereira

Leukemia & lymphoma v. 60, n. 1, p. 172-179, 2019

Abingdon 2019

Online access. The library also has physical copies.

4
Material Type:
Conference Paper
Add to e-Shelf

Bortezomib (Btz) dose intensity is the strongest predictor for overall survival (OS) in mantle cell lymphoma (MCL) patients (Pts) not considered for transplantation, receiving frontline Btz plus rituximab, cyclosphosphamide, doxorubicin, and prednisone (VR-CAP) therapy in the phase 3 LYM 3002 study

Tadeusz Robak Huiqiang Huang; Jie Jim; Jun Shu; Ting Liu; Olga S Samailova; Juliana Pereira; Halyna Pylypenko; Gregor Verhoef; Noppadol Siritanaratkul; Evgenii A Osmanov; Julia Alexeeva; Jiri Mayer; Xiaonan Hong; Yoshiharu Maeda; Brendan Rooney; Helgi van de Velde; Franco Cavalli; Annual Meeting and Exposition / ASH 2014 (56. San Francisco/EUA

Blood New York v. 124, n. 21, res. 4412, suppl, 2014

New York 2014

Online access. The library also has physical copies.

5
Material Type:
Article
Add to e-Shelf

Bortezomib-based therapy for newly diagnosed mantle-cell lymphoma

Tadeusz Robak Huiqiang Huang; Jie Jun; Jun Zhu; Ting Liu; Olga Samoilova; Halyna Pylpenko; Gregor Verhoef; Noppadol Siritanaratkul; Evgenii Osmanov; Julia Alexeeva; Juliana Pereira; Johannes Drach; Jiri Mayer; Xiaonan Hong; Rumiko Okamoto; Lixia Pei; Brendan Rooney; Helgi van de Velde; Franco Cavalli

The New England Journal of Medicine Boston v. 372, n. 8, p. 944-953, 2015

Boston 2015

Available at FM - Fac. Medicina    (BCSEP 093 2015 )(GetIt)

6
Synthesis and Applications of tert-Butanesulfinamide
Material Type:
Article
Add to e-Shelf

Synthesis and Applications of tert-Butanesulfinamide

Robak, MaryAnn T ; Herbage, Melissa A ; Ellman, Jonathan A

Chemical reviews, 2010-06, Vol.110 (6), p.3600-3740 [Peer Reviewed Journal]

United States: American Chemical Society

Full text available

7
Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Material Type:
Article
Add to e-Shelf

Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Eichhorst, B. ; Robak, T. ; Montserrat, E. ; Ghia, P. ; Hillmen, P. ; Hallek, M. ; Buske, C.

Annals of oncology, 2015-09, Vol.26, p.v78-v84 [Peer Reviewed Journal]

England: Elsevier Ltd

Full text available

8
Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Material Type:
Article
Add to e-Shelf

Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Eichhorst, B. ; Robak, T. ; Montserrat, E. ; Ghia, P. ; Niemann, C.U. ; Kater, A.P. ; Gregor, M. ; Cymbalista, F. ; Buske, C. ; Hillmen, P. ; Hallek, M. ; Mey, U.

Annals of oncology, 2021-01, Vol.32 (1), p.23-33 [Peer Reviewed Journal]

England: Elsevier Ltd

Full text available

9
Venetoclax–Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia
Material Type:
Article
Add to e-Shelf

Venetoclax–Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia

Seymour, John F ; Kipps, Thomas J ; Eichhorst, Barbara ; Hillmen, Peter ; D’Rozario, James ; Assouline, Sarit ; Owen, Carolyn ; Gerecitano, John ; Robak, Tadeusz ; De la Serna, Javier ; Jaeger, Ulrich ; Cartron, Guillaume ; Montillo, Marco ; Humerickhouse, Rod ; Punnoose, Elizabeth A ; Li, Yan ; Boyer, Michelle ; Humphrey, Kathryn ; Mobasher, Mehrdad ; Kater, Arnon P

The New England journal of medicine, 2018-03, Vol.378 (12), p.1107-1120 [Peer Reviewed Journal]

United States: Massachusetts Medical Society

Full text available

10
Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia
Material Type:
Article
Add to e-Shelf

Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia

Brown, Jennifer R. ; Eichhorst, Barbara ; Hillmen, Peter ; Jurczak, Wojciech ; Kaźmierczak, Maciej ; Lamanna, Nicole ; O’Brien, Susan M. ; Tam, Constantine S. ; Qiu, Lugui ; Zhou, Keshu ; Simkovic, Martin ; Mayer, Jiri ; Gillespie-Twardy, Amanda ; Ferrajoli, Alessandra ; Ganly, Peter S. ; Weinkove, Robert ; Grosicki, Sebastian ; Mital, Andrzej ; Robak, Tadeusz ; Osterborg, Anders ; Yimer, Habte A. ; Salmi, Tommi ; Wang, Megan-Der-Yu ; Fu, Lina ; Li, Jessica ; Wu, Kenneth ; Cohen, Aileen ; Shadman, Mazyar

The New England journal of medicine, 2023-01, Vol.388 (4), p.319-332 [Peer Reviewed Journal]

United States: Massachusetts Medical Society

Full text available

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Resource Type 

  1. Articles  (298)
  2. Conference Proceedings  (10)
  3. Datasets  (5)
  4. Reports  (4)
  5. Other  (1)
  6. Reviews  (1)
  7. Book Chapters  (1)
  8. More options open sub menu

Creation Date 

From To
  1. Before1998  (23)
  2. 1998To2003  (76)
  3. 2004To2009  (81)
  4. 2010To2016  (60)
  5. After 2016  (80)
  6. More options open sub menu

Language 

  1. English  (319)
  2. Japanese  (20)
  3. Russian  (1)
  4. French  (1)
  5. More options open sub menu

Suggested New Searches

Ignore my query and look for everything

by this author/creator:

  1. Robak, T
  2. Pereira, J
  3. Siritanaratkul, N
  4. Verhoef, G
  5. Mayer, J

Searching Remote Databases, Please Wait

  • Searching for
  • inscope:(USP_VIDEOS),scope:("PRIMO"),scope:(USP_FISICO),scope:(USP_EREVISTAS),scope:(USP),scope:(USP_EBOOKS),scope:(USP_PRODUCAO),primo_central_multiple_fe
  • Show me what you have so far